Related Experiment Video

Updated: Jul 7, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Skp2 suppresses p53-dependent apoptosis by inhibiting p300

Mayumi Kitagawa1, Sang Hyun Lee, Frank McCormick

  • 1Cancer Research Institute and Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94115, USA.

Molecular Cell
|February 5, 2008
PubMed

Insights

Skp2, an oncogenic protein, suppresses cancer cell apoptosis by interfering with the p53 pathway. Targeting Skp2 could offer a new cancer therapy strategy by restoring p53 function.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Skp2 is an oncogenic F-box protein implicated in tumor malignancy.
  • Skp2 overexpression correlates with higher tumor grade and reduced apoptosis.

Purpose of the Study:

  • To investigate the role of Skp2 in regulating p53-mediated apoptosis.
  • To elucidate the molecular mechanism by which Skp2 affects p53 function.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • In vitro binding assays.
  • Western blotting to assess protein levels and modifications.
  • Functional assays measuring apoptosis and cell growth.

Main Results:

  • Skp2 directly interacts with the p300 coactivator, disrupting the p300-p53 complex.
  • Skp2 antagonizes p300-mediated p53 acetylation and transactivation.
  • Depletion of Skp2 restores p53 function and promotes apoptosis.
  • Ectopic p300 expression rescues p53 activity in Skp2-overexpressing cells.

Conclusions:

  • Skp2 inhibits p53-dependent apoptosis by antagonizing the p300-p53 interaction.
  • Skp2 acts as a negative regulator of the p53 signaling pathway in cancer cells.
  • Skp2 represents a promising therapeutic target for cancer treatment.

More Related Videos

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...